Robot-assisted gait training in multiple sclerosis patients: a randomized trial.

Area of Science:

• Neurology
• Rehabilitation Medicine
• Biomedical Engineering

Background:

• Locomotor activity is crucial for multiple sclerosis (MS) patients.
• Robotic-assisted body weight-supported treadmill training shows promise for neurological gait impairments.
• The efficacy of robotic-assisted gait training (RAGT) in MS patients remains under investigation.

Purpose of the Study:

• To compare the effectiveness of RAGT versus conventional walking treatment (CWT) for gait and generalized functions in stable MS patients.
• To evaluate RAGT's impact on gait parameters, functional status, and quality of life in MS.
• To assess the long-term effects of RAGT and CWT at 3 and 6 months post-treatment.

Main Methods:

• Prospective randomized controlled trial involving 12 sessions of RAGT or CWT.
• Participants included MS patients with Expanded Disability Status Scale (EDSS) scores of 5-7.
• Primary outcomes: gait parameters; Secondary outcomes: functional and quality of life measures (FIM, EDSS).

Main Results:

• No significant difference in gait or functional improvements between RAGT and CWT groups.
• Both RAGT and CWT led to significant short-term improvements in gait, FIM, and EDSS scores.
• Most gait and functional benefits diminished by the 6-month follow-up.

Conclusions:

• Robot-assisted gait training (RAGT) is a feasible and safe intervention for MS patients.
• RAGT may serve as an effective supplementary therapy for MS patients with significant walking disabilities.
• Further research is needed to optimize RAGT protocols for sustained functional gains in MS.